NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/14/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization868.62 mln
Float30.07 mln
Earnings Date11/09/2026
EPS
1.69
Decent
P / E
12.37
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.72
Likely reliable
1-Year Forecast
22.00
Modest upside
Relative Strength
66
/ 100
Outperforming
Business Description
Amphastar Pharmaceuticals is a drug maker based in Rancho Cucamonga, California, operating across the United States, China, and France since 1996. The company produces and sells a broad range of injectable, inhaled, and nasal medicines, covering both branded and generic treatments for conditions such as severe low blood sugar, asthma, opioid overdose, blood clots, and osteoporosis, among others. Amphastar also supplies raw pharmaceutical ingredients, including insulin, to support broader drug manufacturing needs.